Company Overview
Avexa, formed in 2004, is an Australian drug-discovery company based in Melbourne, Victoria.
Avexa's business is the discovery and development of anti-infective pharmaceutical medicines for the treatment of serious human infectious diseases.
Avexa's principal research programs focus on the discovery of innovative medicines for the treatment of the diseases caused by:
- Human Immunodeficiency Virus (HIV);
- Vancomycin- and methicillin-resistant bacteria.
Each of these programs represents an area of significant medical need and high market potential and is designed to discover and develop innovative compounds which have a competitive edge.
